logo
  • About
    • AI in Hematology
    • The Platform
    • Our Manifesto
  • Pilots
    • Our use cases
    • Use cases metadata
  • Training
    • Training – Wave 1
    • Training – Wave 2
    • Educational Committee
  • Team
    • Partners
    • Advisory Board
  • Events
  • Publications
  • News
  • Show all
  • Articles
  • Clinical trials
  • Deliverables
  • Papers
  • Posters & Abstracts
  • Pre-prints
Papers

May 2, 2025

Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes

Papers

October 9, 2024

Data-driven, harmonised classification system for myelodysplastic syndromes: a consensus paper from the International Consortium for Myelodysplastic Syndromes

Papers

June 14, 2024

MOSAIC: An Artificial Intelligence–Based Framework for Multimodal Analysis, Classification, and Personalized Prognostic Assessment in Rare Cancers

Papers

May 9, 2024

Personalized Timing for Allogeneic Stem-Cell Transplantation in Hematologic Neoplasms: A Target Trial Emulation Approach Using Multistate Modeling and Microsimulation

Papers

May 9, 2024

Clinical and Genomic-Based Decision Support System to Define the Optimal Timing of Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Myelodysplastic Syndromes

Papers

April 6, 2024

SYNDSURV: A simple framework for survival analysis with data distributed across multiple institutions

  • 1
  • 2
  • 3
  • …
  • 5

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 101017549.

© GenoMed4All. All rights reserved

Privacy Policy | Terms of Use